Rockwell Medical Announces Triferic(TM) ESA-Sparing PRIME Study Published ... - Nasdaq PDF Print
Nasdaq
WIXOM, Mich., July 13, 2015 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services ...
Company Update (NASDAQ:RMTI): Rockwell Medical Inc Announces Triferic(TM

...

 
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.